Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes

Diabetes Care

Volumn 35, Issue 8, 2012, Pages

  Heymann, Anthony D ^a,b   Cohen, Yossi ^a   Chodick, Gabriel ^a,b  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C;

ADULT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN DETERMINATION; HUMAN; ISRAEL; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 84864380654     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2527     Document Type: Letter

References (5)

1. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review andmeta-analysis. Blood Cells Mol Dis 2009;42:267-278
2. Cappai G, Songini M, Doria A, Cavallerano JD, LorenziM. Increased prevalence of proliferative retinopathy in patientswith type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase. Diabetologia 2011;54:1539-1542
3. Gaskin RS, Estwick D, Peddi R. G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus. Ethn Dis 2001;11:749-754
4. Lee JW, Choi AH, Ham M, et al. G6PD upregulation promotes pancreatic beta-cell dysfunction. Endocrinology 2011;152:793-803
5. Heymann AD, Chodick G, Halkin H, et al. The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization. Diabetes Res Clin Pract 2006;71:290-298